$CON
Concentra Group Holdings Parent, Inc. Stock $con

$con Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024038538 Filed on August 27, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024 Q1
Revenue	$489.6M	$477.9M	$467.6M
YoY Change	3.31%	2.32%
Cost Of Revenue	$351.1M	$339.3M	$337.0M
YoY Change
Gross Profit	$138.5M	$138.6M	$130.6M
YoY Change
Gross Profit Margin	28.29%	29.01%	27.93%
Selling, General & Admin	$37.09M	$37.23M	$34.91M
YoY Change
% of Gross Profit	26.77%	26.85%	26.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.21M	$17.87M	$18.49M
YoY Change
% of Gross Profit	10.98%	12.89%	14.15%
Operating Expenses	$52.30M	$55.10M	$53.11M
YoY Change
Operating Profit	$86.23M	$83.94M	$77.50M
YoY Change	6.53%	2.24%
Interest Expense	-$21.37M	$205.0K	-$10.08M
YoY Change	33289.06%	1105.88%
% of Operating Profit	-24.78%	0.24%	-13.01%
Other Income/Expense, Net
YoY Change
Pretax Income	$62.17M	$71.16M	$65.42M
YoY Change	-10.71%	0.75%
Income Tax	$16.42M	$18.10M	$15.14M
% Of Pretax Income	26.4%	25.43%	23.14%
Net Earnings	$44.34M	$51.74M	$48.96M
YoY Change	-16.51%	-1.91%	5.82%
Net Earnings / Revenue	9.06%	10.83%	10.47%
Basic Earnings Per Share	$0.37	$0.50
Diluted Earnings Per Share	$0.37	$0.50	$0.39
COMMON SHARES
Basic Shares Outstanding	126.6M shares	104.1M shares
Diluted Shares Outstanding	120.8M shares	104.1M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$136.8M	$50.67M	$49.55M
YoY Change
Cash & Equivalents	$136.8M	$50.67M
Short-Term Investments
Other Short-Term Assets	$30.79M	$38.66M	$48.30M
YoY Change
Inventory
Prepaid Expenses
Receivables	$232.2M	$229.0M	$229.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$410.0M	$320.3M	$327.5M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$191.1M	$186.9M	$577.0M
YoY Change
Goodwill	$1.235B	$1.233B
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.975M	$10.42M	$8.647M
YoY Change
Total Long-Term Assets	$2.071B	$2.043B	$2.039B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$410.0M	$320.3M	$327.5M
Total Long-Term Assets	$2.071B	$2.043B	$2.039B
Total Assets	$2.481B	$2.363B	$2.366B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$177.6M	$23.67M	$24.65M
YoY Change
Accrued Expenses	$74.41M	$229.4M	$222.0M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.737M	$4.682M	$6.636M
YoY Change
Total Short-Term Liabilities	$269.5M	$265.2M	$275.6M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$1.473B	$423.0M	$473.2M
YoY Change
Other Long-Term Liabilities	$24.19M	$23.02M	$377.0M
YoY Change
Total Long-Term Liabilities	$24.19M	$23.02M	$850.2M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$269.5M	$265.2M	$275.6M
Total Long-Term Liabilities	$24.19M	$23.02M	$850.2M
Total Liabilities	$2.180B	$1.093B	$1.170B
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	$0.00	$784.2M
YoY Change
Common Stock	$277.8M	$462.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$277.8M	$1.247B	$1.196B
YoY Change
Total Liabilities & Shareholders Equity	$2.481B	$2.363B	$2.366B
YoY Change

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$44.34M	$51.74M	$48.96M
YoY Change	-16.51%	-1.91%	5.82%
Depreciation, Depletion And Amortization	$15.21M	$17.87M	$18.49M
YoY Change
Cash From Operating Activities	$65.91M	$70.43M	$44.62M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	$15.15M	$15.26M	$17.23M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.819M	$0.00	-$5.121M
YoY Change
Cash From Investing Activities	-$16.96M	-$15.26M	-$22.35M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	37.21M	-54.05M	-4.092M
YoY Change
NET CHANGE
Cash From Operating Activities	65.91M	70.43M	44.62M
Cash From Investing Activities	-16.96M	-15.26M	-22.35M
Cash From Financing Activities	37.21M	-54.05M	-4.092M
Net Change In Cash	86.15M	1.117M	18.18M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	$65.91M	$70.43M	$44.62M
Capital Expenditures	$15.15M	$15.26M	$17.23M
Free Cash Flow	$50.76M	$55.17M	$27.39M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.233
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.233
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104094000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104094000	shares
CY2024Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-3676000	usd
CY2023Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-3676000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-526000	usd
CY2022Q4	us-gaap	Members Capital MembersCapital	979343000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	46264000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-253000	usd
CY2023Q1	cghp	Adjustments To Members Contributed Capital Contributions From Parent AdjustmentsToMembersContributedCapitalContributionsFromParent	2797000	usd
CY2023Q1	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	178000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	221000	usd
CY2023Q1	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-435000	usd
CY2023Q1	us-gaap	Members Capital MembersCapital	1028179000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	52742000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-297000	usd
CY2023Q2	cghp	Distribution Made To Parent DistributionMadeToParent	-3352000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	300000	usd
CY2023Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	343000	usd
CY2023Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-3000	usd
CY2023Q2	us-gaap	Members Capital MembersCapital	1077220000	usd
	us-gaap	Profit Loss ProfitLoss	103338000	usd
	us-gaap	Profit Loss ProfitLoss	101463000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36355000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36593000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	59000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	185000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3676000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-526000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-42000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	14000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	332000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	178000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1618000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3265000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12829000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27011000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1224000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	9944000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4217000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1796000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11307000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-966000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115055000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	99541000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5144000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1446000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4382000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32494000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25864000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	23000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	20000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37615000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31672000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	60000000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	70000000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	6618000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	5471000	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	4378000	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	4074000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	2643000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	3130000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	7742000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	555000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-58145000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-72288000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19295000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4419000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31374000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37657000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50669000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33238000	usd
	us-gaap	Interest Paid Net InterestPaidNet	19512000	usd
	us-gaap	Interest Paid Net InterestPaidNet	22784000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	34009000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	32445000	usd
	cghp	Number Of Occupational Health Centers Operated By Entity NumberOfOccupationalHealthCentersOperatedByEntity	547	health_center
	cghp	Number Of Onsite Clinics Operated By Entity NumberOfOnsiteClinicsOperatedByEntity	154	clinic
CY2024Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	42	state
CY2024Q1	cghp	Member Interest Convertible Conversion Ratio MemberInterestConvertibleConversionRatio	1
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div>
CY2024Q2	cghp	Number Of Less Than Wholly Owned Subsidiaries NumberOfLessThanWhollyOwnedSubsidiaries	5	less_than_wholly_owned_subsidiary
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	16477000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	16772000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1053000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	914000	usd
CY2024Q1	cghp	Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests	1174000	usd
CY2023Q1	cghp	Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests	1656000	usd
CY2024Q1	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-1901000	usd
CY2023Q1	cghp	Noncontrolling Interest Change In Redemption Value Net NoncontrollingInterestChangeInRedemptionValueNet	-436000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	18257000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	16466000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1078000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	993000	usd
CY2024Q2	cghp	Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests	793000	usd
CY2023Q2	cghp	Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests	610000	usd
CY2024Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	132000	usd
CY2023Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-3000	usd
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	18410000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	16852000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	25077000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	24296000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	49867000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	48424000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	109000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	261000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	320000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	512000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	77000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	100000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	132000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	203000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5293000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	4920000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	10549000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	10034000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	30556000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	29577000	usd
	us-gaap	Lease Cost LeaseCost	60868000	usd
	us-gaap	Lease Cost LeaseCost	59173000	usd
CY2024Q2	cghp	Long Term Debt Gross And Finance Lease Obligation LongTermDebtGrossAndFinanceLeaseObligation	427730000	usd
CY2023Q4	cghp	Long Term Debt Gross And Finance Lease Obligation LongTermDebtGrossAndFinanceLeaseObligation	474746000	usd
CY2024Q2	cghp	Long Term Debt And Finance Lease Obligation Repayments Of Principal Remainder Of Fiscal Year LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear	3819000	usd
CY2024Q2	cghp	Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Next Twelve Months LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1024000	usd
CY2024Q2	cghp	Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Two LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo	351000	usd
CY2024Q2	cghp	Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Three LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree	397000	usd
CY2024Q2	cghp	Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Four LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour	447000	usd
CY2024Q2	cghp	Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal After Year Four LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour	421692000	usd
CY2024Q2	cghp	Long Term Debt Gross And Finance Lease Obligation LongTermDebtGrossAndFinanceLeaseObligation	427730000	usd
CY2024Q2	cghp	Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent	57439000	usd
CY2023Q4	cghp	Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent	62824000	usd
CY2024Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	42983000	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	41488000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	55484000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	71755000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	3014000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	399000	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	158920000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	176466000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	477915000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	467079000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	945513000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	923377000	usd
CY2024Q1	cghp	Member Interest Convertible Conversion Ratio MemberInterestConvertibleConversionRatio	1
CY2024Q2	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	104094000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	51737000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	51737000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104094000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104094000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	100693000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	100693000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104094000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104094000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.97
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2023Q2	us-gaap	Profit Loss ProfitLoss	54032000	usd
	us-gaap	Profit Loss ProfitLoss	101463000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1290000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2457000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	52742000	usd
	us-gaap	Net Income Loss NetIncomeLoss	99006000	usd
CY2023Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	148000	usd
CY2023Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	148000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	287000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	287000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	52594000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	52594000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	98719000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	98719000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	52594000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	52594000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103962000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103962000	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	98719000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	98719000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103952000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103952000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2023Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	148000	usd
CY2023Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	148000	usd
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	292000	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	287000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	287000	usd
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	302000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	52742000	usd
	us-gaap	Net Income Loss NetIncomeLoss	99006000	usd
CY2024Q1	cghp	Loss Contingency Number Of Patients LossContingencyNumberOfPatients	4000000	patient
CY2024Q1	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	6	class_action_lawsuit
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-038538-index-headers.html	Edgar Link	pending
0001628280-24-038538-index.html	Edgar Link	pending
0001628280-24-038538.txt	Edgar Link	pending
0001628280-24-038538-xbrl.zip	Edgar Link	pending
cghp-20240630.htm	Edgar Link	pending
cghp-20240630.xsd	Edgar Link	pending
cghp-630202410qxex311.htm	Edgar Link	pending
cghp-630202410qxex312.htm	Edgar Link	pending
cghp-630202410qxex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
cghp-20240630_cal.xml	Edgar Link	unprocessable
cghp-20240630_def.xml	Edgar Link	unprocessable
cghp-20240630_lab.xml	Edgar Link	unprocessable
cghp-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cghp-20240630_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CON
Concentra Group Holdings Parent, Inc. Stock $con

2024 Q3 Form 10-Q Financial Statement

#000162828024038538 Filed on August 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CON Concentra Group Holdings Parent, Inc. Stock $con

2024 Q3 Form 10-Q Financial Statement

#000162828024038538 Filed on August 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CON
Concentra Group Holdings Parent, Inc. Stock $con